Forex Books Talking

19 is 2,232 which equates to a 8.4% gain from 12/31/14 and a 5.9% rise from current levels just think that we could drop several percentage points before a solid rally, just as we experienced in 2014

For the first five months of the year, the DJIA and S&P 500 Index are up around 1% and 2%, respectively, while NASDAQ kicks butt, up to nintey nine of nine

mpressive-more so than in recent weeks. In fact, on Friday, volume on the S&P 500 of 3.9 billion shares was the largest since April there of one strock verifivcation

30th, when the index traded 4.5 billion hares and dropped 1% (ironically from the 2107 level to 2085.)We continue to see slow shifts on the negative side with respect to divergence in the 52 week high/low figures and advance/declines. As

was anything but stellar for stocks. Total advances for the month were 812 versus 3314 decliners, a difference of nearly four times. AAII Sentiment Survey (courtesy of AAII.com, figures rounded)

Orbotech (NASDAQ—ORBK—$20.90—NR) was tabbed as our small cap stock pick of the year and featured again last week as we forex trading market world wide

thought the valuation warranted another table pounding. The stock did not disappoint and broke through the $20 mark for the first time in 8 years on news of a new order

years on news of a new order. Volume was huge and the stock reached a peak return for the week of 10%. More upside is still in the cards, in our view.Skechers USA (NYSE—SKX—$105.87—NR

continues to “run” higher as the company announced it has the #2 brand position in America’s athletic footwear market. We were on the stock early and it has not disappointed, with the shares up 58%. Start taking a little off the table, if you have not already done so.

We probably should have pulled the trigger on 1-800 Flowers (NASDAQ—FLWS—$9.51—NR) a couple of weeks ago, but now looks like the run is over. Therefore,

we are removing the stock from our “Pick ‘em” list. Ditto for SkullCandy (NASDAQ—SKUL—$7.50—NR), a stock that did so well for us earlier in 2015 has been rotten of late. We had it under

Speaking of blips, our short term trading idea off of the VIX and a market downturn was anything but profitable as VelocityShares Daily 2x VIX ETN (NYSE—TVIX—$0.89—NR) has gone the wrong

way. Never fear, as this is still a great day-trading and risky vehicle when things are headed south. Speaking of short term trading, Plasmatech BioPharma

em” list. Ditto for SkullCandy (NASDAQ—SKUL—$7.50—NR), a stock that did so well for us earlier in 2015 has been rotten of late. We had it under review and in hindsight dropped the ball by not removing it earlier.